08:00 , Dec 20, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes; obesity G protein-coupled receptor family C group 5 member B (GPRC5B) Mouse studies suggest inhibiting GPRC5B could help treat...